A. Fredriksen

发表

DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza

K. Roux, S. Mjaaland, B. Bogen, 2013, The Journal of Immunology.

Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3

B. Bogen, I. Øynebråten, J. Hinkula, 2014, PloS one.

The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype

S. Mjaaland, G. Tunheim, B. Bogen, 2013, PloS one.

Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen‐specific CD4+8+ thymocytes

I. Sandlie, B. Bogen, K. Schjetne, 2005, European journal of immunology.

Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells

T. Holmøy, F. Vartdal, B. Bogen, 2005, European journal of immunology.

Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates.

T. Espevik, G. Tunheim, B. Bogen, 2007, Vaccine.

Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes

I. Sandlie, G. Tunheim, B. Bogen, 2005, Journal of leukocyte biology.

T Cells from Multiple Sclerosis Patients Recognize Multiple Epitopes on Self‐IgG

T. Holmøy, F. Vartdal, B. Bogen, 2007, Scandinavian journal of immunology.

DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease

J. Tregoning, B. Bogen, J. U. McDonald, 2016, Front. Immunol..

responses, enabling Faster resolution of influenza Disease

J. Tregoning, B. Bogen, J. U. McDonald, 2016 .

The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules

Even Fossum, B. Bogen, G. Grødeland, 2018, ImmunoHorizons.

Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.

B. Bogen, A. Fredriksen, 2007, Blood.

Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors1

B. Bogen, K. Schjetne, A. Fredriksen, 2007, The Journal of Immunology.

Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells

I. Sandlie, B. Bogen, A. Fredriksen, 2012, Front. Oncol..

Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.

B. Bogen, A. Corthay, K. Thompson, 2006, Haematologica.

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination

L. Fugger, G. Løset, B. Bogen, 2016, The Journal of Immunology.

DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.

I. Sandlie, B. Bogen, A. Fredriksen, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines.

B. Bogen, P. Ruffini, G. Grødeland, 2010, Vaccine.

Targeted idiotype‐fusion DNA vaccines for human multiple myeloma: preclinical testing

B. Bogen, T. Gedde-Dahl, K. Thompson, 2011, European journal of haematology.

A therapeutic antigen-presenting cell-targeting DNA vaccine VB10.16 in HPV16-positive high-grade cervical intraepithelial neoplasia: results from a phase 1/2a trial.

P. Hillemanns, L. Woelber, G. Böhmer, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses

M. Tolstrup, G. Norheim, C. W. Wold, 2023, Scientific reports.

InfluenzaAntibody-Mediated Protection against MHC Class II Molecules Rapidly Induces DNA Vaccine that Targets Hemagglutinin to

K. Roux, S. Mjaaland, B. Bogen, 2013 .